Skip to Content

Precipio Inc PRPO

Morningstar Rating
$5.08 −0.17 (3.24%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PRPO is trading at a 438% premium.
Price
$5.12
Fair Value
$3.34
Uncertainty
Very High
1-Star Price
$63.62
5-Star Price
$5.55
Economic Moat
Xpcrk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRPO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$5.25
Day Range
$5.005.35
52-Week Range
$4.318.99
Bid/Ask
$5.00 / $5.16
Market Cap
$7.47 Mil
Volume/Avg
5,870 / 5,891

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.44
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
57

Valuation

Metric
PRPO
Price/Earnings (Normalized)
Price/Book Value
0.57
Price/Sales
0.44
Price/Cash Flow
Price/Earnings
PRPO

Financial Strength

Metric
PRPO
Quick Ratio
0.51
Current Ratio
0.78
Interest Coverage
−257.00
Quick Ratio
PRPO

Profitability

Metric
PRPO
Return on Assets (Normalized)
−26.87%
Return on Equity (Normalized)
−36.44%
Return on Invested Capital (Normalized)
−33.46%
Return on Assets
PRPO
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
FjlyqtvnvNpnq$204.0 Bil
Danaher Corp
DHR
MzldnbmqbdTdfgsr$180.4 Bil
IQVIA Holdings Inc
IQV
SccmrvnzSrrwk$40.9 Bil
IDEXX Laboratories Inc
IDXX
MflrtpxdTmjssw$38.7 Bil
Agilent Technologies Inc
A
KhzsrsnvSsw$38.4 Bil
Mettler-Toledo International Inc
MTD
BykvktjxrhWdrjwz$28.7 Bil
Icon PLC
ICLR
QlttzfzwJtpgxq$27.3 Bil
Illumina Inc
ILMN
YvzbwxjRcnnd$18.2 Bil
Waters Corp
WAT
JfkjnjnnhxKhnc$18.0 Bil
Labcorp Holdings Inc
LH
GklmcdjnclNcvhdqk$17.8 Bil

Sponsor Center